TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.
News  ›  GlobeNewswire Inc.

TELIX URGENT CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights Before January 9th

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Bragar Eagel & Squire, P.C.
TELIX URGENT CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights Before January 9th

A class action lawsuit has been filed against Telix Pharmaceuticals Limited in the U.S. District Court for the Southern District of Indiana. The lawsuit alleges that defendants made false and misleading statements regarding prostate cancer therapeutic candidates, overstated supply chain quality, and misrepresented business operations and prospects during the period of February 21, 2025 to August 28, 2025. Investors have until January 9, 2026 to apply to be appointed as lead plaintiff.

Insights
AU   positive

Gained 9.08% after reporting Q3 earnings above estimates

TLX   negative

The company is the subject of a class action lawsuit alleging material misstatements about therapeutic progress, supply chain quality, and business operations. These allegations suggest potential fraud and have resulted in investor losses, which is significantly negative for the company's reputation and stock value.

Keywords
#class action lawsuit #securities fraud #misleading statements #prostate cancer therapeutics #supply chain #investor losses #lead plaintiff deadline

Tickers
TLX
← Prev: Associated Capital Reports Estimated Fourth Quarter and Full Year Results